A comprehensive view of Blood Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.
Biopharma firm CureVac NV and the University of Texas MD Anderson Cancer Center partner to develop novel mRNA-based cancer vaccines; the collaboration will focus on creating vaccines for hematological and solid tumor indications
Published:
April 18, 2024
by Marketline - Deals
|
INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "HSD17B13 INHIBITORS AND/OR DEGRADERS"
Published:
April 15, 2024
by U.S. Fed News
|
Australia Patent: REGENERON PHARMACEUTICALS Files Application for 'COMPOSITIONS AND METHODS FOR EXPRESSING FACTOR IX FOR HEMOPHILIA B THERAPY'
Published:
April 12, 2024
by Australian Government
|
MA S2640: To improve sickle cell care
Published:
April 11, 2024
by Massachusetts 193rd General Court
|
Becton, Dickinson & Co. (BD) Garners Industry Recognition for Employee Well-being and Advances in IV Therapy and Blood Cancer Diagnostics
Published:
April 10, 2024
by Industry Intelligence Inc.
|
Ask us about our Bioeconomy market view